In their March 2018 quarterly update they provided an initial FY19 forecast of 60% growth. The March 2019 update provided no forecast and this investor presentation only talks about 'continued growth' and a 'sales pipeline'. I would be very interested to see the company provide an actual revenue forecast range.
- Forums
- ASX - By Stock
- Ann: Investor Presentation - May 2019
In their March 2018 quarterly update they provided an initial...
-
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SE1 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online